MeSH terms
-
Animals
-
Antiviral Agents / adverse effects
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
COVID-19 / virology
-
COVID-19 Drug Treatment
-
Cytidine / adverse effects
-
Cytidine / analogs & derivatives*
-
Cytidine / metabolism
-
Cytidine / pharmacology
-
Cytidine / therapeutic use
-
Cytidine / toxicity
-
DNA / biosynthesis
-
Evolution, Molecular
-
Genome, Viral
-
Humans
-
Hydroxylamines / adverse effects
-
Hydroxylamines / metabolism
-
Hydroxylamines / pharmacology*
-
Hydroxylamines / therapeutic use
-
Mutagenesis*
-
Mutagenicity Tests
-
Phosphorylation
-
RNA Virus Infections / drug therapy
-
RNA Virus Infections / virology
-
RNA Viruses / drug effects*
-
RNA Viruses / genetics
-
RNA, Viral / biosynthesis
-
RNA, Viral / genetics
-
Ribonucleosides / metabolism
-
SARS-CoV-2 / drug effects*
-
SARS-CoV-2 / genetics
Substances
-
Antiviral Agents
-
Hydroxylamines
-
RNA, Viral
-
Ribonucleosides
-
Cytidine
-
DNA
-
N(4)-hydroxycytidine
-
molnupiravir